OptiBiotix Health Plc Cash Flow Conversion Efficiency
OptiBiotix Health Plc cash flow conversion efficiency. Based on the latest financial reports, OptiBiotix Health Plc (OPTI) has a cash flow conversion efficiency ratio of -0.106x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-895.00K ≈ $-108.90 USD) by net assets (GBX8.42 Million ≈ $1.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of OptiBiotix Health Plc (2008–2024)
Cash flow conversion efficiency of OptiBiotix Health Plc from 2008 to 2024. This chart illustrates how OptiBiotix Health Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View OPTI stock price for real-time trading data and today's change.
OptiBiotix Health Plc Cash Flow Conversion Ratio Explained
OptiBiotix Health Plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
OptiBiotix Health Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OptiBiotix Health Plc ranked by their cash flow conversion efficiency. Also see how much is OptiBiotix Health Plc worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GREENBANK CAPITAL
F:2TL
|
N/A |
|
The Siam Cement Public Company Limited
F:TCM1
|
0.018x |
|
Lion Group Holding Ltd
NASDAQ:LGHL
|
-0.097x |
|
Landore Resources Plc
LSE:LND
|
-1.772x |
|
Clean Power Hydrogen PLC
LSE:CPH2
|
-0.397x |
|
Argo Blockchain PLC
LSE:ARB
|
0.135x |
|
TROUBADOUR RESOURCES INC.
F:2QD0
|
-0.017x |
|
Walker Crips Group PLC
LSE:WCW
|
-0.456x |
Annual Cash Flow Conversion Efficiency for OptiBiotix Health Plc (2008–2024)
The table below shows the annual cash flow conversion efficiency of OptiBiotix Health Plc from 2008 to 2024. Review OptiBiotix Health Plc (OPTI) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX8.40 Million ≈ $1.02K |
GBX-1.77 Million ≈ $-215.11 |
-0.211x | -22.32% |
| 2023-12-31 | GBX8.87 Million ≈ $1.08K |
GBX-1.53 Million ≈ $-185.79 |
-0.172x | -69.24% |
| 2022-12-31 | GBX10.90 Million ≈ $1.33K |
GBX-1.11 Million ≈ $-134.93 |
-0.102x | -18.11% |
| 2021-12-31 | GBX18.17 Million ≈ $2.21K |
GBX-1.56 Million ≈ $-190.37 |
-0.086x | -9.96% |
| 2020-12-31 | GBX11.85 Million ≈ $1.44K |
GBX-927.96K ≈ $-112.91 |
-0.078x | +77.37% |
| 2019-12-31 | GBX4.98 Million ≈ $606.08 |
GBX-1.72 Million ≈ $-209.67 |
-0.346x | -98.06% |
| 2018-11-30 | GBX7.06 Million ≈ $859.29 |
GBX-1.23 Million ≈ $-150.09 |
-0.175x | +29.81% |
| 2017-11-30 | GBX7.05 Million ≈ $857.26 |
GBX-1.75 Million ≈ $-213.32 |
-0.249x | +0.09% |
| 2016-11-30 | GBX5.00 Million ≈ $608.74 |
GBX-1.25 Million ≈ $-151.61 |
-0.249x | +3.34% |
| 2015-11-30 | GBX3.82 Million ≈ $464.39 |
GBX-983.46K ≈ $-119.66 |
-0.258x | -69.62% |
| 2014-11-30 | GBX4.65 Million ≈ $565.66 |
GBX-706.24K ≈ $-85.93 |
-0.152x | +95.33% |
| 2013-11-30 | GBX115.88K ≈ $14.10 |
GBX-376.79K ≈ $-45.84 |
-3.251x | -33.04% |
| 2012-07-31 | GBX440.35K ≈ $53.58 |
GBX-1.08 Million ≈ $-130.94 |
-2.444x | -4398.03% |
| 2010-07-31 | GBX773.00K ≈ $94.05 |
GBX-42.00K ≈ $-5.11 |
-0.054x | +32.29% |
| 2009-07-31 | GBX810.00K ≈ $98.55 |
GBX-65.00K ≈ $-7.91 |
-0.080x | -145.20% |
| 2008-07-31 | GBX825.00K ≈ $100.38 |
GBX-27.00K ≈ $-3.29 |
-0.033x | -- |
About OptiBiotix Health Plc
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential… Read more